Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice

Anticancer Research

Volumn 28, Issue 6 A, 2008, Pages 3717-3723

  Bathen, Tone F ^a   Holmgren, Kristin ^a   Lundemo, Anne Gøril ^a   Hjelstuen, Mari H ^b   Krokan, Hans E ^a   Gribbestad, Ingrid S ^a   Schønberg, Svanhild A ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colon cancer; Lipids; Omega 3; Omega 6; SW620; Xenograft

Indexed keywords

CORN OIL; FISH OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHORYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL GROWTH PROCESSES; COLONIC NEOPLASMS; DIET; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 58149160021     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Caygill CPJ and Hill MJ: Fish, omega-3 fatty-acids and human colorectal and breast-cancer mortality. Eur J Cancer Prev 4: 329-332, 1995.
2. Caygill CPJ, Charlett A and Hill MJ: Fat, fish, fish oil and cancer. Br J Cancer 74: 159-164, 1996.
3. Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, Duffy S, Gallagher RP, Iscovich JM, DengAo j, Kaaks R, Kune GA, Kune S, Lee HP, Lee M, Miller AB, Peters RK, Potter JD, Riboli E, Slattery ML, Trichopoulos D, Tuyns A, Tzonou A, Watson LE, Whittemore AS, WuWilliams AH and Shu Z: The relationship between dietary fat intake and risk of colorectal cancer: Evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 8: 215-228, 1997.
4. Kojima M, Wakai K, Tokudome S, Suzuki K, Tamakoshi K, Watanabe Y, Kawado M, Hashimoto S, Hayakawa N, Ozasa K, Toyoshima H, Suzuki S, Ito Y and Tamakoshi A for the JACC Study Group: Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: A prospective study. Am J Epidemiol 161: 462-471, 2005.
5. Kimura Y, Kono S, Toyomura K, Nagano J, Mizoue T, Moore MA, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H and Imaizumi N: Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci 98: 590-597, 2007.
6. Reddy BS, Narisawa T, Vukusich D, Weisburger JH and Wynder EL: Effect of quality and quantity of dietary-fat and dimethylhydrazine in colon carcinogenesis in rats: Proc Soc Exp Biol Med 151: 237-239, 1976.
7. Reddy BS: Omega-3 fatty acids in colorectal cancer prevention. Int J Cancer 112: 1-7, 2004.
8. Schonberg SA, Lundemo AG, Fladvad T, Holmgren K, Bremseth H, Nilsen A, Gederaas O, Tvedt KE, Egeberg KW and Krokan HE: Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and down-regulate sterol regulatory element-binding protein 1. FEBS J 273: 2749-2765, 2006.
9. Reddy BS: Nutritional factors and colon cancer. Crit Rev Food Sci Nutr 35: 175-190, 1995.
10. Larsson SC, Kumlin M, Ingelman-Sundberg M and Wolk A: Dietary long-chain omega-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79: 935-945, 2004.
11. Reddy BS and Sugie S: Effect of different levels of omega-3 and omega-6 fatty-acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 48: 6642-6647, 1988.
12. Rao CV, Simi B, Wynn TT, Garr K and Reddy BS: Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A(2), phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res 56: 532-537, 1996.
13. Narayanan BA, Narayanan NK and Reddy BS: Docosahexaenoic acid-regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 19: 1255-1262, 2001.
14. Eliyahu G, Kreizman T and Degani H: Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies. Int J Cancer 120: 1721-1730, 2007.
15. Glunde K and Serkova NJ: Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 7: 1109-1123, 2006.
16. Morse DL, Gray H, Payne CM and Gillies RJ: Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 4: 1495-1504, 2005.
17. Morse DL, Raghunand N, Sadarangani P, Murthi S, Job C, Day S, Howison C and Gillies RJ: Response of choline metabolites to docetaxel therapy is quantified in vivo by localized P-31 MRS of human breast cancer xenografts and in vitro by high-resolution P-31 NMR spectroscopy of cell extracts. Magn Reson Med 58: 270-280, 2007.
18. Bligh EG and Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917,1959.
19. Coleman LJ, Landstrom EK, Royle PJ, Bird AR and McIntosh GH: A diet containing alpha-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoxymethane-treated rats. J Nutr 132: 2312-2318, 2002.
20. Dwivedi C, Muller LA, Goetz-Parten DE, Kasperson K and Mistry VV: Chemopreventive effects of dietary mustard oil on colon tumor development. Cancer Lett 196: 29-34, 2003.
21. Rao CV, Hirose Y, Indranie C and Reddy BS: Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61: 1927-1933, 2001.
22. Kato T, Hancock RL, Mohammadpour H, McGregor B, Manalo P, Khaiboullina S, Hall MR, Pardini L and Pardini RS: Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett 187: 169-177, 2002.
23. Sakaguchi M, Rowley S, Kane N, Imray C, Davies A, Jones C, Newbold M, Keighley MR, Baker P and Neoptolemos JP: Reduced tumour growth of the human colonic cancer cell lines COLO-320 and HT-29 in vivo by dietary omega-3 lipids. Br J Cancer 62: 742-747, 1990.
24. Hardman WE, Munoz J Jr and Cameron IL: Role of lipid peroxidation and antioxidant enzymes in omega-3 fatty acid induced suppression of breast cancer xenograft growth in mice. Cancer Cell Int 2: 10, 2002.
25. Maehle L, Eilertsen E, Mollerup S, Schonberg S, Krokan HE and Haugen A: Effects of omega-3 fatty acids during neoplastic progression and comparison of in vitro and in vivo sensitivity of two human tumour cell lines. Br J Cancer 71: 691-696, 1995.
26. Boudreau MD, Sohn KH, Rhee SH, Lee SW, Hunt JD and Hwang DH: Suppression of tumor cell growth both in nude mice and in culture by omega-3 polyunsaturated fatty acids: Mediation through cyclooxygenase-independent pathways. Cancer Res 61: 1386-1391, 2001.
27. Schmitz G and Ecker J: The opposing effects of omega-3 and omega-6 fatty acids. Prog. Lipid Res 47: 147-155, 2008.
28. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K and Dubois RN: Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention. J Clin Oncol 23: 254-266, 2005.
29. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and Dubois RN: Up-regulation of cyclooxygenase-2 gene-expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
30. Rao CV, Hirose Y, Indranie C, and Reddy BS: Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61: 1927-1933, 2001
31. Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, Nelson MT, Emory TH, Turtle TM, Yee D and Garwood M: Neoadjuvant chemotherapy of locally advanced breast cancer: Predicting response with in vivo 1H MR spectroscopy - A pilot study at 4T. Radiology 233: 424-431, 2004.
32. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A and Rath GK: Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84: 1016-1022, 2001.
33. Ackerstaff E, Glunde K and Bhujwalla ZM: Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 90: 525-533, 2003.
34. Glunde K, Jie C and Bhujwalla ZM: Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64: 4270-4276, 2004.
35. Sitter B, Sonnewald U, Spraul M, Fjosne HE and Gribbestad IS: High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15: 327-337, 2002.